BBCA PHARMA, a subsidiary of BBCA Group, is the first pharmaceutical listed company in Anhui province (It was listed in Shenzhen Stock Exchange in 2000 and the Stock Code is 000153). Established for almost 60 years, BBCA PHARMA has successively earned a reputation of China’s Top 100 Pharmaceutical Industries for several years since 2006.

Integrating R&D, manufacturing with sales, BBCA PHARMA has developed into a national high and new tech enterprise, leading with large-volume transfusion (the annual amount is over 500 million bottles/bags) and assisting by analgesic-antipyretic, cardiovascular, antibiotic products, etc. 53 international production lines certified by GMP, its products include more than ten kinds of dosage forms and 300 varieties of drugs, involving fields of bio-pharmaceutical, chemical pharmaceutical, Chinese Herbal Medicine and APIs.